Literature DB >> 16107356

White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.

H Jokinen1, H Kalska, R Mäntylä, R Ylikoski, M Hietanen, T Pohjasvaara, M Kaste, T Erkinjuntti.   

Abstract

OBJECTIVES: Cerebral white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are a recognised risk factor for post-stroke dementia. Their specific relations to cognitive impairment are still not well known. The purpose of this study was to explore how the severity and location of WMHs predict neuropsychological test performance in the context of other brain lesions in elderly stroke patients.
METHODS: In the Helsinki Stroke Aging Memory Study, 323 patients, aged from 55 to 85 years, completed a detailed neuropsychological test battery and MRI 3 months after an ischaemic stroke. The demographic and MRI predictors of cognition were studied with sequential linear regression analyses.
RESULTS: After age, education and total infarct volume were controlled for, the overall degree of WMHs predicted poor performance in tests of mental speed, executive functions, memory, and visuospatial functions, but not in those of short term memory storage or verbal conceptualisation. However, the contribution of separate white matter regions was relatively low. Only the lesions along the bodies of lateral ventricles were independently associated with speed and executive measures. Additionally, general cortical atrophy clearly predicted a wide range of cognitive deficits while infarct volume had less relevance. Further analyses revealed that executive functions act as a strong mediator between the relationship of WMHs to memory and visuospatial functions.
CONCLUSIONS: The degree of WMHs is independently related to post-stroke cognitive decline. The most affected cognitive domains seem to be executive functions and speed of mental processing, which may lead to secondary deficits of memory and visuospatial functions.

Entities:  

Mesh:

Year:  2005        PMID: 16107356      PMCID: PMC1739804          DOI: 10.1136/jnnp.2004.055657

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

Review 1.  Adult clinical neuropsychology: lessons from studies of the frontal lobes.

Authors:  Donald T Stuss; Brian Levine
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

Review 2.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.

Authors:  Sibel Tekin; Jeffrey L Cummings
Journal:  J Psychosom Res       Date:  2002-08       Impact factor: 3.006

3.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.

Authors:  D Mungas; W J Jagust; B R Reed; J H Kramer; M W Weiner; N Schuff; D Norman; W J Mack; L Willis; H C Chui
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

4.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

5.  Neuropsychological profiles associated with subcortical white matter alterations and Parkinson's disease: implications for the diagnosis of dementia.

Authors:  D J Libon; B Bogdanoff; N Leopold; R Hurka; J Bonavita; S Skalina; R Swenson; H L Gitlin; S K Ball
Journal:  Arch Clin Neuropsychol       Date:  2001-01       Impact factor: 2.813

6.  The relationship of subcortical MRI hyperintensities and brain volume to cognitive function in vascular dementia.

Authors:  Ronald A Cohen; Robert H Paul; Brian R Ott; David J Moser; Tricia M Zawacki; William Stone; Norman Gordon
Journal:  J Int Neuropsychol Soc       Date:  2002-09       Impact factor: 2.892

7.  Brain structure and cognition in a community sample of elderly Latinos.

Authors:  C C Wu; D Mungas; C I Petkov; J L Eberling; P A Zrelak; M H Buonocore; J A Brunberg; M N Haan; W J Jagust
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

8.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.

Authors:  C DeCarli; D G Murphy; M Tranh; C L Grady; J V Haxby; J A Gillette; J A Salerno; A Gonzales-Aviles; B Horwitz; S I Rapoport
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

9.  White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients.

Authors:  Emma J Burton; Rose Anne Kenny; John O'Brien; Sally Stephens; Michael Bradbury; Elise Rowan; Raj Kalaria; Michael Firbank; Keith Wesnes; Clive Ballard
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

10.  MRI correlates of executive dysfunction in patients with ischaemic stroke.

Authors:  R Vataja; T Pohjasvaara; R Mäntylä; R Ylikoski; A Leppävuori; M Leskelä; H Kalska; M Hietanen; H J Aronen; O Salonen; M Kaste; T Erkinjuntti
Journal:  Eur J Neurol       Date:  2003-11       Impact factor: 6.089

View more
  27 in total

Review 1.  Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke.

Authors:  Rebecca F Gottesman; Argye E Hillis
Journal:  Lancet Neurol       Date:  2010-09       Impact factor: 44.182

2.  Cognitive profile of subcortical ischaemic vascular disease.

Authors:  H Jokinen; H Kalska; R Mäntylä; T Pohjasvaara; R Ylikoski; M Hietanen; O Salonen; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

3.  Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study.

Authors:  Hanna Jokinen; Charlotte Ryberg; Hely Kalska; Raija Ylikoski; Egill Rostrup; Mikkel B Stegmann; Gunhild Waldemar; Sofia Madureira; José M Ferro; Elizabeth C W van Straaten; Philip Scheltens; Frederik Barkhof; Franz Fazekas; Reinhold Schmidt; Giovanna Carlucci; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

4.  Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study.

Authors:  Perri Segal; Yoav Kohn; Yehuda Pollak; Gheona Altarescu; Esti Galili-Weisstub; Annick Raas-Rothschild
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

Review 5.  Cerebrovascular Dysfunction in Preeclamptic Pregnancies.

Authors:  Erica Shields Hammer; Marilyn J Cipolla
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

6.  Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression.

Authors:  María J Marquine; Deborah K Attix; Larry B Goldstein; Gregory P Samsa; Martha E Payne; Gordon J Chelune; David C Steffens
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

7.  White matter hyperintensities and medication adherence.

Authors:  Kathleen C Insel; Sheryl L Reminger; Chao-Pin Hsiao
Journal:  Biol Res Nurs       Date:  2008-10       Impact factor: 2.522

8.  Hippocampal volume is an independent predictor of cognitive performance in CADASIL.

Authors:  Mike O'Sullivan; Elmar Ngo; Anand Viswanathan; Eric Jouvent; Andreas Gschwendtner; Philipp G Saemann; Marco Duering; Chahin Pachai; Marie-Germaine Bousser; Hugues Chabriat; Martin Dichgans
Journal:  Neurobiol Aging       Date:  2007-10-25       Impact factor: 4.673

9.  White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48.

Authors:  Wei Wen; Perminder S Sachdev; Jason J Li; Xiaohua Chen; Kaarin J Anstey
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

Review 10.  Computerized Cognitive Rehabilitation of Attention and Executive Function in Acquired Brain Injury: A Systematic Review.

Authors:  Yelena Bogdanova; Megan K Yee; Vivian T Ho; Keith D Cicerone
Journal:  J Head Trauma Rehabil       Date:  2016 Nov/Dec       Impact factor: 2.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.